Latest Industry Insights

BD Biosciences has developed a method with the potential to transform both single cell transcriptional profiling and high parameter proteomics

We spoke to Thermo Fisher Scientific's Andy Felton to find out more about the latest advancements in Next Generation Sequencing.

In modern agriculture, insecticides are extensively used to manage insect populations and protect crops. Despite heavy regulation, misuse occurs, meaning that insecticides sometimes make their way into the surrounding environment and ultimately entering the food chain. Here we discuss the issue of insecticides in eggs.

Particle Works, a member of the Blacktrace Group, manufactures high-performance nano- and microstructured materials with precisely controlled particle size, shape and architecture. We caught up with Mark Gilligan, Group CEO, to discuss the people behind the particles.

We recently caught up with BBI’s Managing Director, Liam Taylor, to discuss the expansion of lateral flow testing as a tool for diagnostics and patient monitoring.

We spoke to Gus Salem, President - IDEX Health and Science to discuss where the future of microfluidics may be headed, the company's continued expansion into the microfluidics marketplace and some of its future goals.

This article describes some new in vitro approaches to toxicology, as well as current initiatives, to facilitate the verification of methods and conclusions, and to enhance data sharing and scientific discovery.

Microfluidics has rapidly grown in popularity over the last few years, as indicated by the sky-rocketing number of publications featuring microfluidic applications. We caught up with Mark Gilligan, CEO and founder of Dolomite Microfluidics, to discuss the latest developments in microfluidics and how the company is positioning itself to support future developments.

We spoke to Dr Philipp Pagel, CMO at numares AG, to learn about some of the limitations of current in vitro diagnostics, and how software based technologies can help overcome some of these.

We spoke to Dirk Löffert, Ph.D., CEO of Biomillenia, to learn about some of the challenges of isolating live bacterial species, and how microbiome-on-a-chip technology can help overcome some of these.